glp 1 agonist pharmacology Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide Receptor Agonists: A Scoping Review glp-1_analogs [TUSOM | Pharmwiki]

Short acting agents (such as exenetide) exert their effect mostly by slowing gastric emptying, which reduces post-prandial glucose levels

You want to reduce food noise

Potential selection criteria might include: Adolescents with BMI 95th percentile for age and sex History of unsuccessful comprehensive lifestyle interventions Presence of obesity-related comorbidities Absence of contraindications (eating disorders, severe mental illness) Adequate family support and resources for monitoring Informed consent and assent processes completed Monitoring and Follow-up Comprehensive monitoring protocols are essential for safe and effective use of GLP-1 RAs in adolescents

Your clinician will likely evaluate: Your Primary Goal: Is the focus blood sugar control, weight loss, or both

Open-field test Locomotor activity was evaluated using an open-field test

Results You Can Expect Average 520% weight loss over 612 months Improved blood sugar control (HbA1c) Reduced waist circumference and visceral fat Enhanced energy and mood Decreased cravings and emotional eating Results may vary